The Serum Institute of India (SII), the world’s largest vaccine manufacturer by volume, and the Indian Council of Medical Research (ICMR), India’s leading body for biomedical research, today announced the completion of trial enrollment Phase 3 clinical trials for Covishield or Oxford covid vaccine in India. Covishield has been developed …
Read More »Serum Institute Completes Registration for Phase III Trial in India
